Objectives Owing to the underrepresentation of early-stage disease in randomised trials and inconsistent clinical evidence, ...
Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence suggests that biologic therapies may differentially influence the development ...
Objectives Smoking is recognised as one of the strongest environmental risk factors for the development of rheumatoid ...
Over the last decade, the outlook for patients with rheumatoid arthritis (RA) has improved, but there is growing interest in ...
Multicentric reticulohistiocytosis (MRH) is a rare non-Langerhans cell histiocytosis characterised by erosive arthritis and papulonodular skin lesions, frequently associated with autoimmune features.
Objectives Nerandomilast, a selective phosphodiesterase 4B (PDE4B) inhibitor, has been extensively investigated for the treatment of pulmonary fibrosis; however, its therapeutic potential and ...
Background Involvement of hands is a frequent finding in polymyalgia rheumatica (PMR) and can lead to misclassification as late-onset rheumatoid arthritis (RA). Objective To compare the inflammatory ...
Objective To identify the best evidence on the efficacy of non-pharmacological interventions in reducing fatigue in people with inflammatory rheumatic and musculoskeletal diseases (I-RMDs) and to ...
Objectives Development of a new ultrasound (US) synovitis score (SONography in Arthritis and Rheumatism (SONAR)-7) with evaluation of its diagnostic performance in a cohort of patients with psoriatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results